BCHE and Lewy body dementia: At the time of study, there were 15 DLB patients taking antidepressants; 13 taking benzodiazepines; 24 taking cholinesterase inhibitors; seven taking antipsychotics; 10 taking anticholinergic agents or dopamine agonists; and four taking NMDA receptor antagonists.